Aditxt, INC DEF 14A proxy statements

Aditxt Inc. has issued a definitive proxy statement for its 2026 Annual Meeting of Stockholders, scheduled for May 1, 2026, detailing proposals including director elections, auditor ratification, executive compensation votes, and a significant reverse stock split authorization.

Aditxt, Inc. calls a Special Meeting to approve a reverse stock split, a corporate name change to bitXbio, Inc., and the issuance of shares related to past financings and new employee equity plans.

Aditxt, Inc. outlines a transformative bitXbio strategy, proposing a name change to bitXbio, Inc., an Employee Stock Purchase Plan, and updates on Pearsanta's planned IPO and Evofem's uplisting efforts.

Aditxt, Inc. has filed definitive additional materials related to a proxy statement with the U.S. Securities and Exchange Commission.

Aditxt, Inc. announced its 2025 Annual Meeting, proposing a reverse stock split to meet Nasdaq listing requirements and revealing significant reliance on insider loans.

Aditxt is convening a special meeting to seek stockholder approval for several proposals, including the issuance of common stock related to convertible preferred stock and warrants, and a reverse stock split.

Aditxt, Inc. announces its 2024 annual meeting of stockholders to be held on August 7, 2024, outlining proposals including director elections, auditor ratification, stock issuance approvals, and a potential reverse stock split.